321 related articles for article (PubMed ID: 10680585)
21. Inhibition of cardiovascular activity following microinjection of novel opioid-like neuropeptide nociceptin (orphanin FQ) into the rat rostral ventrolateral medulla.
Chu X; Xu N; Li P; Mao L; Wang JQ
Brain Res; 1999 May; 829(1-2):134-42. PubMed ID: 10350539
[TBL] [Abstract][Full Text] [Related]
22. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
23. Pharmacological profile of the cyclic nociceptin/orphanin FQ analogues c[Cys10,14]N/OFQ(1-14)NH2 and c[Nphe1,Cys10,14]N/OFQ(1-14)NH2.
Kitayama M; Barnes TA; Carra G; McDonald J; Calo G; Guerrini R; Rowbotham DJ; Smith G; Lambert DG
Naunyn Schmiedebergs Arch Pharmacol; 2003 Dec; 368(6):528-37. PubMed ID: 14598020
[TBL] [Abstract][Full Text] [Related]
24. Effect of intrathecal nocistatin on nociceptin/orphanin FQ analgesia in chronic constriction injury rat.
Ma F; Xie H; Dong ZQ; Wang YQ; Wu GC
Brain Res; 2003 Oct; 988(1-2):189-92. PubMed ID: 14519541
[TBL] [Abstract][Full Text] [Related]
25. Functional blockade of opioid analgesia by orphanin FQ/nociceptin.
King M; Chang A; Pasternak GW
Biochem Pharmacol; 1998 May; 55(9):1537-40. PubMed ID: 10076548
[TBL] [Abstract][Full Text] [Related]
26. Bidirectional modulatory effect of orphanin FQ on morphine-induced analgesia: antagonism in brain and potentiation in spinal cord of the rat.
Tian JH; Xu W; Fang Y; Mogil JS; Grisel JE; Grandy DK; Han JS
Br J Pharmacol; 1997 Feb; 120(4):676-80. PubMed ID: 9051307
[TBL] [Abstract][Full Text] [Related]
27. Orphanin FQ potentiates formalin-induced pain behavior and antagonizes morphine analgesia in rats.
Zhu CB; Cao XD; Xu SF; Wu GC
Neurosci Lett; 1997 Oct; 235(1-2):37-40. PubMed ID: 9389590
[TBL] [Abstract][Full Text] [Related]
28. Disulfiram attenuates morphine or methadone withdrawal syndrome in mice.
de Cordé A; Krząścik P; Wolińska R; Kleczkowska P; Filip M; Bujalska-Zadrożny M
Behav Pharmacol; 2018 Aug; 29(5):393-399. PubMed ID: 29462108
[TBL] [Abstract][Full Text] [Related]
29. Conditioning processes contribute to severity of naloxone-precipitated withdrawal from acute opioid dependence.
Schulteis G; Morse AC; Liu J
Psychopharmacology (Berl); 2004 Oct; 175(4):463-72. PubMed ID: 15083263
[TBL] [Abstract][Full Text] [Related]
30. Matricaria chamomilla extract inhibits both development of morphine dependence and expression of abstinence syndrome in rats.
Gomaa A; Hashem T; Mohamed M; Ashry E
J Pharmacol Sci; 2003 May; 92(1):50-5. PubMed ID: 12832855
[TBL] [Abstract][Full Text] [Related]
31. Noradrenaline release in rat locus coeruleus is regulated by both opioid and alpha(2) -adrenoceptors.
Nakai T; Hayashi M; Ichihara K; Wakabayashi H; Hoshi K
Pharmacol Res; 2002 May; 45(5):407-12. PubMed ID: 12123629
[TBL] [Abstract][Full Text] [Related]
32. Conditioned opioid withdrawal decreases nociceptin/orphanin FQ levels in the frontal cortex and olfactory tubercle.
Walker JR; Terenius L; Koob GF
Neuropsychopharmacology; 2002 Aug; 27(2):203-11. PubMed ID: 12093594
[TBL] [Abstract][Full Text] [Related]
33. [Antagonistic effect of orphanin FQ on morphine analgesia in rat brain].
Tian JH; Xu W; Fang Y; Han JS
Sheng Li Xue Bao; 1997 Jun; 49(3):333-8. PubMed ID: 9812820
[TBL] [Abstract][Full Text] [Related]
34. Orphanin FQ acts as a supraspinal, but not a spinal, anti-opioid peptide.
Grisel JE; Mogil JS; Belknap JK; Grandy DK
Neuroreport; 1996 Sep; 7(13):2125-9. PubMed ID: 8930972
[TBL] [Abstract][Full Text] [Related]
35. Distinct effect of intracerebroventricular and intrathecal injections of nociceptin/orphanin FQ in the rat formalin test.
Wang JL; Zhu CB; Cao XD; Wu GC
Regul Pept; 1999 Feb; 79(2-3):159-63. PubMed ID: 10100930
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of the NMDA receptor antagonist, dizocilpine (MK-801), on the development of morphine dependence.
Makimura M; Sugimoto H; Shinomiya K; Kabasawa Y; Fukuda H
J Toxicol Sci; 1996 May; 21(2):135-41. PubMed ID: 8780997
[TBL] [Abstract][Full Text] [Related]
37. Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice.
Lichtman AH; Sheikh SM; Loh HH; Martin BR
J Pharmacol Exp Ther; 2001 Sep; 298(3):1007-14. PubMed ID: 11504797
[TBL] [Abstract][Full Text] [Related]
38. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
Azizi H; Ranjbar-Slamloo Y; Semnanian S
Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
[TBL] [Abstract][Full Text] [Related]
39. Antagonism of orexin type 1 receptors in the locus coeruleus attenuates signs of naloxone-precipitated morphine withdrawal in rats.
Azizi H; Mirnajafi-Zadeh J; Rohampour K; Semnanian S
Neurosci Lett; 2010 Oct; 482(3):255-9. PubMed ID: 20667500
[TBL] [Abstract][Full Text] [Related]
40. Effects of nociceptin (13-17) in pain modulation at supraspinal level in mice.
Chen LX; Wang ZZ; Wu H; Fang Q; Chen Y; Wang R
Neurosci Lett; 2002 Oct; 331(2):95-8. PubMed ID: 12361849
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
